Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
16,300 Shares in Merck & Co., Inc. $MRK Purchased by Dorato Capital Management
Dorato Capital Management recently acquired 16,300 shares of Merck & Co., Inc. (NYSE:MRK) valued at approximately $1.809 million, making it the fund’s 15th-largest holding. This purchase comes amidst significant insider selling, with executives offloading over $38 million worth of shares in the last 90 days. Merck has several positive catalysts, including EU approval for Keytruda in ovarian cancer and strong Phase 3 results for an oral PCSK9 candidate, leading to a consensus “Moderate Buy” rating from analysts with an average price target of $127.13.